3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Oropharyngeal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Anus Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anal Canal Carcinoma
1
Interventions
Gemcitabine
19
130-nm albumin-bound paclitaxel
16
Specimen Handling
15
Irinotecan
11
Magnetic Resonance Spectroscopy
10
Fluorouracil
10
Leucovorin
9
Biopsy
9
Oxaliplatin
8
pembrolizumab
7
Cyclophosphamide
7
fludarabine
6
Cisplatin
5
Pemetrexed
4
Cetuximab
4
Albumin-Bound Paclitaxel
4
zimberelimab
3
trastuzumab deruxtecan
3
olaparib
3
irinotecan sucrosofate
3
durvalumab
3
dehydroftorafur
3
aldesleukin
3
Taxes
3
Radiosurgery
3
Nivolumab
3
Immunoglobulin G
3
Disulfides
3
Carboplatin
3
veliparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
Watchful Waiting
×
30 days
×
Clear all
No trials found.